$1.17
6.40% yesterday
Nasdaq, Apr 03, 10:00 pm CET
ISIN
US8723811084
Symbol
TELA

TELA Bio Inc Stock price

$1.17
-1.17 50.00% 1M
-1.35 53.57% 6M
-1.85 61.26% YTD
-4.13 77.92% 1Y
-10.08 89.60% 3Y
-6.83 85.38% 5Y
-12.18 91.24% 10Y
Nasdaq, Closing price Thu, Apr 03 2025
-0.08 6.40%
ISIN
US8723811084
Symbol
TELA
Sector

Key metrics

Market capitalization $46.27m
Enterprise Value $36.66m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.53
P/S ratio (TTM) P/S ratio 0.67
P/B ratio (TTM) P/B ratio 1.62
Revenue growth (TTM) Revenue growth 18.56%
Revenue (TTM) Revenue $69.30m
EBIT (operating result TTM) EBIT $-41.70m
Free Cash Flow (TTM) Free Cash Flow $-42.58m
Cash position $52.67m
EPS (TTM) EPS $-1.39
P/E forward negative
P/S forward 0.54
EV/Sales forward 0.43
Short interest 1.52%
Show more

Is TELA Bio Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

TELA Bio Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a TELA Bio Inc forecast:

4x Buy
80%
1x Hold
20%

Analyst Opinions

5 Analysts have issued a TELA Bio Inc forecast:

Buy
80%
Hold
20%

Financial data from TELA Bio Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
69 69
19% 19%
100%
- Direct Costs 23 23
24% 24%
33%
46 46
16% 16%
67%
- Selling and Administrative Expenses 78 78
6% 6%
113%
- Research and Development Expense 8.81 8.81
8% 8%
13%
-41 -41
6% 6%
-59%
- Depreciation and Amortization 1.01 1.01
25% 25%
1%
EBIT (Operating Income) EBIT -42 -42
5% 5%
-60%
Net Profit -38 -38
19% 19%
-55%

In millions USD.

Don't miss a Thing! We will send you all news about TELA Bio Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

TELA Bio Inc Stock News

Neutral
Seeking Alpha
14 days ago
TELA Bio, Inc. (NASDAQ:TELA ) Q4 2024 Earnings Conference Call March 20, 2025 4:30 PM ET Company Participants Greg Chodaczek - The Gilmartin Group Antony Koblish - Co-founder, President and Chief Executive Office Roberto Cuca - Chief Operating Officer and Chief Financial Officer Conference Call Participants Frank Takkinen - Lake Street Capital Markets Caitlin Cronin - Canaccord Genuity David Tu...
Neutral
GlobeNewsWire
15 days ago
MALVERN, Pa., March 20, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the fourth quarter and full year ended December 31, 2024.
Neutral
GlobeNewsWire
about one month ago
MALVERN, Pa., Feb. 27, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report fourth quarter and full year 2024 financial results on Thursday, March 20, 2025. TELA Bio's management will host a conference call and webcast a...
More TELA Bio Inc News

Company Profile

TELA Bio, Inc. is a commercial stage medical technology company. It focuses on designing, developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company offers a portfolio of advanced reinforced tissue matrices that improve clinical outcomes and reduce overall costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. TELA Bio was founded by Antony Koblish and Maarten Persenaire on April 17, 2012 and is headquartered in Malvern, PA.

Head office United States
CEO Antony Koblish
Employees 209
Founded 2012
Website www.telabio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today